Breathing easier: 3-in-1 inhaler tested for COPD relief
NCT ID NCT05535972
Summary
This study looked at how well a 3-in-1 inhaler called Trelegy works for people with symptomatic COPD in their daily lives. Over 460 adults with COPD used the inhaler for 12 weeks. Researchers measured changes in their breathing, shortness of breath, and overall health status to see if the treatment helped.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Dongguan, 523326, China
Conditions
Explore the condition pages connected to this study.